Nectar Lifescience Ltd (NECLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 216478, "name": "Nectar Lifesci.", "stock_name": "Nectar Lifesci.", "full_name": "Nectar Lifescience Ltd", "name_url": "stocks-analysis/nectar-lifesci", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "10.74", "chg": 0.19, "chgp": "1.8%", "dir": 1, "prev_price": "10.55", "mcapval": "208.64 Cr", "mcap": "Micro Cap", "scripcode": 532649, "symbol": "NECLIFE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE023H01027", "curr_date": "Aug 12, 04:01 PM", "curr_time": "16:28 PM", "last_traded_at": "Aug 12, 04:01 PM IST", "bse_nse_vol": "1.91 lacs", "exc_status": "Active", "traded_date": "Aug 12, 2026", "traded_date_str": "2026 08 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nectar-lifesci-216478-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Nectar Lifescience Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-nectar-lifescience-ltd-4148727", "imagepath": "", "date": "2026-08-11 23:17:24", "description": "The next results date for Nectar Lifescience Ltd is scheduled for 14 August 2026...." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4139676", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NectarLifescien_mojoScore_4139676.png", "date": "2026-08-06 10:10:42", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4121157", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NectarLifescien_mojoScore_4121157.png", "date": "2026-07-26 10:10:16", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Jul 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4103716", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NectarLifescien_mojoScore_4103716.png", "date": "2026-07-15 10:10:33", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Jul 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 July 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4088387", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NectarLifescien_mojoScore_4088387.png", "date": "2026-07-04 10:10:19", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4068965", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NectarLifescien_mojoScore_4068965.png", "date": "2026-06-23 10:10:32", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Nectar Lifescience Declines 3.78% Amid Mounting Losses and Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-declines-378-amid-mounting-losses-and-margin-pressures-4053114", "imagepath": "", "date": "2026-06-14 15:00:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Q4 FY26 results reveal deepening operational losses</p>\n <p><strong>2 June:</strong> Flat quarterly performance reported amidst margin pressures</p>\n <p><strong>5 June:</strong> Week closes at Rs.11.96, down 3.78%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12.21</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.11.96</div><div class=\"stat-change negative\">-3.78%</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4046505", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NectarLifescien_mojoScore_4046505.png", "date": "2026-06-11 10:10:22", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Nectar Lifescience Ltd Reports Flat Quarterly Performance Amidst Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-reports-flat-quarterly-performance-amidst-margin-pressures-4030802", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NectarLifescien_fintrenddot_4030802.png", "date": "2026-06-02 11:00:11", "description": "Nectar Lifescience Ltd reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from previous negative trends but still reflecting significant operational challenges. Despite a stabilisation in revenue growth, the company’s profitability metrics deteriorated sharply, underscoring persistent margin pressures in a competitive pharmaceutical sector." } ], "total": 630, "sid": "216478", "stock_news_url": "https://www.marketsmojo.com/news/nectar-lifescience-216478" }, "announcements": [ { "caption": "Board Meeting Intimation for Financial Results And Other Business Matters.", "datetime": "10-Aug-2026", "details": "Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended on June 30 2026 and matters related thereto and other business matters if any.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director", "datetime": "06-Aug-2026", "details": "Please find attached herewith letter of Resignation of Non-Executive Non-Independent Director of the Nectar Lifesciences", "source": "BSE" }, { "caption": "Sale And Surrender Of Leasehold Rights In Land Situated In Jammu", "datetime": "04-Aug-2026", "details": "Please find attached herewith letter of Sale and Surrender of Leasehold Rights in Land Situated in Jammu", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "14 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nectar Lifescience Ltd has declared <strong>5%</strong> dividend, ex-date: 11 Sep 20", "dt": "2020-09-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Nectar Lifescience Ltd has announced <strong>1:10</strong> stock split, ex-date: 12 Nov 08", "dt": "2008-11-12", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Q4 FY26 results reveal deepening operational losses

2 June: Flat quarterly performance reported amidst margin pressures

5 June: Week closes at Rs.11.96, down 3.78%

Read full news article

Nectar Lifescience Ltd is Rated Strong Sell

2026-06-11 10:10:22

Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Nectar Lifescience Ltd Reports Flat Quarterly Performance Amidst Margin Pressures

2026-06-02 11:00:11

Nectar Lifescience Ltd reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from previous negative trends but still reflecting significant operational challenges. Despite a stabilisation in revenue growth, the company’s profitability metrics deteriorated sharply, underscoring persistent margin pressures in a competitive pharmaceutical sector.

Read full news article